Match each highly specific neurologic clinical vignette to the most appropriate initial or confirmatory diagnostic laboratory test.
- A 38-year-old woman presenting with severe, bilateral optic neuritis, sequential episodes of paraparesis, and intractable vomiting.Serum aquaporin-4 (AQP4) immunoglobulin G testing
- A 24-year-old woman with new-onset severe psychiatric symptoms, autonomic instability, orofacial dyskinesias, and an adnexal mass.Cerebrospinal fluid assay for anti-N-methyl-D-aspartate (NMDA) receptor antibodies
- A 55-year-old man with asymmetric, slowly progressive distal upper extremity weakness without sensory loss, and absent tendon reflexes in the affected limbs.Serum anti-GM1 ganglioside antibody testing
- A 35-year-old woman with a subacute onset of gait ataxia, ophthalmoplegia, and diffuse areflexia following a recent diarrheal illness.Serum anti-GQ1b ganglioside antibody testing
- A 65-year-old man exhibiting rapidly progressive cognitive decline over two months, accompanied by startle myoclonus and akinetic mutism.Cerebrospinal fluid real-time quaking-induced conversion (RT-QuIC) assay
Cevap
Each distinct neurologic presentation matches a highly specific confirmatory laboratory test: NMOSD to AQP4 IgG, anti-NMDA receptor encephalitis to CSF NMDA receptor antibodies, multifocal motor neuropathy to anti-GM1 antibodies, Miller Fisher syndrome to anti-GQ1b antibodies, and Creutzfeldt-Jakob disease to the CSF RT-QuIC assay.
Correctly identifying these diseases requires recognizing highly specific clinical clues (e.g., an adnexal mass pointing to an ovarian teratoma in anti-NMDA receptor encephalitis, or intractable vomiting pointing to area postrema involvement in NMOSD) and knowing their paired autoantibodies or protein assays.
Adım Adım Çözüm
Anahtar Kavram
Targeted laboratory evaluation for specific neuro-immunologic and prion diseases